Monitoring blood flow in ICU patients with severe infection or shock
Part of Infections clinical trials.
This study monitors tiny blood vessels under the tongue using a non-invasive device to see how well blood flows in ICU patients on a breathing machine. Researchers hope to improve care for patients with serious infections or shock.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the intensive care unit (ICU).
- You are on a breathing machine (ventilator).
- It has been less than 24 hours since you were admitted to the ICU.
- You have no known allergy to the textile parts of the monitoring device.
- You do not have severe jaundice (yellowing of skin) or large bruises.
- You are not expected to pass away in the next 24 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study looks at how tiny blood vessels under the tongue work in healthy people and in critically ill ICU patients. For healthy volunteers, it checks normal function; for ICU patients, it measures changes while they are on strong blood-pressure support and a breathing tube.
This study uses special sensor devices worn on your skin to detect early warning signs of sepsis (a dangerous blood infection). By catching sepsis earlier, doctors may be able to treat it faster and help you recover better.
This study looks at a special blood flow monitor (perfusion index) to see if it can help doctors decide when to give blood pressure raising medicines in patients with serious infections. It might help doctors better treat sepsis and septic shock.
This study looks at how well blood flows to the skin of patients with sepsis in the ICU. It aims to see if this can help predict recovery and guide care.
This trial tests a personalized approach to giving IV fluids to patients with sepsis in the emergency department. It uses a device to monitor your heart and blood flow to help doctors decide how much fluid you need, which may improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.